Division of Blood and Marrow Transplantation
Dedicated to exceptional and innovative blood and marrow transplantation patient care, research, and education
The University of Minnesota is an internationally respected pioneer in the area of blood and marrow transplantation (BMT). The first successful human bone marrow transplant was performed at the University of Minnesota in 1968. Other “firsts” include the first transplant to treat a patient with lymphoma (1975), the first transplant to treat an inherited metabolic disease (1982), and the world’s first umbilical cord blood transplant performed using pre-implantation genetic testing to ensure a perfect tissue match (2000). Our clinical program is recognized as the second largest unrelated donor transplant programs in the country, and one of the largest umbilical cord blood transplant centers worldwide.
Patients and Families
For 40 years we have demonstrated expert, excellent, and innovative care to blood and marrow transplant patients throughout their transplant experience. Our Blood and Marrow Transplant program is the oldest and one of the largest, most respected pediatric blood and marrow transplant research programs in the world. Children and adolescents come from around the world to be treated at the University of Minnesota Masonic Children's Hospital.
Pediatric BMT researchers continue to break new ground in the areas of alternative stem cell therapies, cord blood transplantation, genetic engineering to reduce the side effects of BMT and potentially to treat disease, and immune based therapies.
Our faculty and staff are committed to education, for the next generation of health care providers as well as to patients and their families and the general public.